ChromaDex Corp. Names New Directors, Adjusts Executive Pay
Ticker: NAGE · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1386570
| Field | Detail |
|---|---|
| Company | Chromadex Corp. (NAGE) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: CDXC
TL;DR
CDXC board shakeup & new exec pay packages announced.
AI Summary
ChromaDex Corporation announced on February 25, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. Robert L. Smith and Ms. Jennifer L. Grant, to its Board. Additionally, the company entered into new employment agreements with its CEO, Mr. Michael J. Newman, and its CFO, Ms. Laura L. Chen, which include updated compensation packages.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty, but the specific details provided are standard corporate governance actions.
Key Players & Entities
- ChromaDex Corporation (company) — Registrant
- Dr. Robert L. Smith (person) — Newly Elected Director
- Ms. Jennifer L. Grant (person) — Newly Elected Director
- Mr. Michael J. Newman (person) — CEO
- Ms. Laura L. Chen (person) — CFO
- February 25, 2025 (date) — Date of earliest event reported
FAQ
Who were the newly elected directors to ChromaDex's Board?
Dr. Robert L. Smith and Ms. Jennifer L. Grant were elected as new directors to ChromaDex's Board.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 25, 2025.
What are the primary items reported in this Form 8-K?
This Form 8-K reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is ChromaDex Corporation's state of incorporation?
ChromaDex Corporation is incorporated in Delaware.
What is the principal executive office address for ChromaDex Corporation?
The principal executive office address for ChromaDex Corporation is 10900 Wilshire Blvd., Suite 600, Los Angeles, California 90024.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 by Dr. Robert L. Smith regarding ChromaDex Corp. (NAGE).